{"id":1520,"date":"2018-07-30T18:53:07","date_gmt":"2018-07-30T18:53:07","guid":{"rendered":"https:\/\/odan.odanlabdev.ca\/asmacure\/developpement\/"},"modified":"2023-12-15T20:46:47","modified_gmt":"2023-12-16T01:46:47","slug":"developpement","status":"publish","type":"page","link":"https:\/\/odanlab.com\/fr\/developpement\/","title":{"rendered":"D\u00e9veloppement"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\"  style='background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;'><div class=\"fusion-builder-row fusion-row \"><div  class=\"fusion-layout-column fusion_builder_column fusion_builder_column_1_1 fusion-builder-column-0 fusion-one-full fusion-column-first fusion-column-last 1_1\"  style='margin-top:0px;margin-bottom:20px;'><div class=\"fusion-column-wrapper\" style=\"padding: 0px 0px 0px 0px;background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;\"   data-bg-url=\"\"><div class=\"fusion-text\"><p>Le principal produit en d\u00e9veloppement de l&#8217;entreprise, ASM-024, avec son <span style=\"color: #003976;\">nouveau m\u00e9canisme d&#8217;action<\/span>, a d\u00e9montr\u00e9 les capacit\u00e9s d&#8217;anti-inflammation, de la bronchoprotection et de la relaxation des muscles lisses en mod\u00e8les d&#8217;asthme pr\u00e9-clinique. ASM-024 livr\u00e9 en tant qu\u2019une solution pour la n\u00e9bulisation a atteint preuve de concept dans le traitement des patients souffrant d&#8217;asthme dans un essai clinique de phase 2.<\/p>\n<p>La strat\u00e9gie de l&#8217;entreprise a toujours \u00e9t\u00e9 de se concentrer sur le d\u00e9veloppement d&#8217;une formulation de poudre s\u00e8che pour inhalation (DPI). Le DPI est une forme posologique pr\u00e9f\u00e9r\u00e9e qui nous permet d&#8217;administrer un dosage plus faible et plus optimal avec un plus grand d\u00e9p\u00f4t pulmonaire. La formulation de la solution nous a permis de passer plus rapidement \u00e0 la clinique et de d\u00e9montrer une preuve de concept. Avec la preuve de concept d\u00e9montr\u00e9e dans la phase 2 avec la formulation de la solution, Asmacure progresse maintenant dans la phase 2 dans l&#8217;asthme et la MPOC avec une forme posologique DPI.<\/p>\n<h2><span style=\"color: # 003976;\"> Quel est le besoin non satisfait en mati\u00e8re de MPOC? <\/span><\/h2>\n<p>Plus de 200 millions de personnes dans le monde souffrent de maladie pulmonaire obstructive chronique (MPOC). Rien qu&#8217;aux \u00c9tats-Unis, la MPOC affecte jusqu&#8217;\u00e0 15 millions de personnes, dont 15 millions suppl\u00e9mentaires non diagnostiqu\u00e9s. La MPOC est connue pour causer 130 000 d\u00e9c\u00e8s par an aux \u00c9tats-Unis et est maintenant la troisi\u00e8me cause de d\u00e9c\u00e8s. La pr\u00e9valence de la MPOC dans le monde augmente rapidement et est largement due \u00e0 l&#8217;augmentation du nombre de fumeurs et \u00e0 la pollution de l&#8217;environnement. L&#8217;Organisation mondiale de la sant\u00e9 a estim\u00e9 que 2,7 millions de personnes sont mortes de MPOC dans le monde en 2000 et les projets de d\u00e9c\u00e8s par MPOC augmenteraient de plus de 30% dans les 10 ann\u00e9es qui suivraient sans interventions pour r\u00e9duire les risques.<\/p>\n<p>La MPOC est un trouble chronique qui a un certain nombre d&#8217;\u00e9tiologies mais qui est principalement caus\u00e9 par l&#8217;exposition \u00e0 la fum\u00e9e de cigarette et \u00e0 d&#8217;autres polluants inhal\u00e9s. La MPOC est caract\u00e9ris\u00e9e par des modifications fibro-destructives progressives des voies respiratoires et de l&#8217;architecture alv\u00e9olaire qui entra\u00eenent des limitations dans le flux d&#8217;air. Ces modifications physiopathologiques conduisent \u00e0 une obstruction des voies respiratoires peu r\u00e9versible, \u00e0 une hyperr\u00e9activit\u00e9 des voies respiratoires et \u00e0 une alt\u00e9ration de l&#8217;\u00e9change gazeux alv\u00e9olaire. L&#8217;expression clinique la plus courante de la MPOC est une combinaison de bronchite chronique et d&#8217;emphys\u00e8me, bien que chez de nombreux patients, l&#8217;un ou l&#8217;autre pr\u00e9domine. Une toux chronique, un \u00e9claircissement fr\u00e9quent de la gorge, une respiration sifflante et un essoufflement apr\u00e8s un effort l\u00e9ger sont des sympt\u00f4mes courants. La MPOC, commun\u00e9ment identifi\u00e9e dans la 5e d\u00e9cennie de la vie, est une maladie lentement progressive et irr\u00e9versible caract\u00e9ris\u00e9e par une perte progressive de la fonction pulmonaire. \u00c0 mesure que la maladie progresse, les voies respiratoires deviennent plus enflamm\u00e9es, ce qui entra\u00eene un remodelage et les alv\u00e9oles perdent leur \u00e9lasticit\u00e9.<\/p>\n<p>Le principal compos\u00e9 de d\u00e9veloppement d&#8217;Asmacure, ASM-024, pourrait un jour offrir une nouvelle option th\u00e9rapeutique aux m\u00e9decins dans le traitement de la MPOC.<\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"jetpack_post_was_ever_published":false,"footnotes":""},"class_list":["post-1520","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>D\u00e9veloppement - Odan Laboratories Ltd.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"D\u00e9veloppement - Odan Laboratories Ltd.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/\" \/>\n<meta property=\"og:site_name\" content=\"Odan Laboratories Ltd.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/odanlab\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-16T01:46:47+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/\",\"url\":\"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/\",\"name\":\"D\u00e9veloppement - Odan Laboratories Ltd.\",\"isPartOf\":{\"@id\":\"https:\/\/odanlab.com\/#website\"},\"datePublished\":\"2018-07-30T18:53:07+00:00\",\"dateModified\":\"2023-12-16T01:46:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/odanlab.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"D\u00e9veloppement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/odanlab.com\/#website\",\"url\":\"https:\/\/odanlab.com\/\",\"name\":\"Odan Laboratories Ltd.\",\"description\":\"The Leader in Specialty Generic Pharmaceutical Products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/odanlab.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"D\u00e9veloppement - Odan Laboratories Ltd.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/","og_locale":"fr_FR","og_type":"article","og_title":"D\u00e9veloppement - Odan Laboratories Ltd.","og_url":"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/","og_site_name":"Odan Laboratories Ltd.","article_publisher":"https:\/\/www.facebook.com\/odanlab\/","article_modified_time":"2023-12-16T01:46:47+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/","url":"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/","name":"D\u00e9veloppement - Odan Laboratories Ltd.","isPartOf":{"@id":"https:\/\/odanlab.com\/#website"},"datePublished":"2018-07-30T18:53:07+00:00","dateModified":"2023-12-16T01:46:47+00:00","breadcrumb":{"@id":"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/odanlab.com\/fr\/asmacure__trashed\/developpement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/odanlab.com\/fr\/"},{"@type":"ListItem","position":2,"name":"D\u00e9veloppement"}]},{"@type":"WebSite","@id":"https:\/\/odanlab.com\/#website","url":"https:\/\/odanlab.com\/","name":"Odan Laboratories Ltd.","description":"The Leader in Specialty Generic Pharmaceutical Products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/odanlab.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/Pahxdx-ow","_links":{"self":[{"href":"https:\/\/odanlab.com\/fr\/wp-json\/wp\/v2\/pages\/1520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/odanlab.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/odanlab.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/odanlab.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/odanlab.com\/fr\/wp-json\/wp\/v2\/comments?post=1520"}],"version-history":[{"count":6,"href":"https:\/\/odanlab.com\/fr\/wp-json\/wp\/v2\/pages\/1520\/revisions"}],"predecessor-version":[{"id":358259,"href":"https:\/\/odanlab.com\/fr\/wp-json\/wp\/v2\/pages\/1520\/revisions\/358259"}],"wp:attachment":[{"href":"https:\/\/odanlab.com\/fr\/wp-json\/wp\/v2\/media?parent=1520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}